BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31216562)

  • 1. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.
    Baba M; Yokoyama K; Seiriki K; Naka Y; Matsumura K; Kondo M; Yamamoto K; Hayashida M; Kasai A; Ago Y; Nagayasu K; Hayata-Takano A; Takahashi A; Yamaguchi S; Mori D; Ozaki N; Yamamoto T; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Neuropsychopharmacology; 2019 Nov; 44(12):2125-2135. PubMed ID: 31216562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome.
    Takemoto T; Baba M; Yokoyama K; Kitagawa K; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Mori D; Ozaki N; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2022 Mar; 15(1):26. PubMed ID: 35346312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial inheritance of the 3q29 microdeletion syndrome: case report and review.
    Khan WA; Cohen N; Scott SA; Pereira EM
    BMC Med Genomics; 2019 Mar; 12(1):51. PubMed ID: 30885185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
    Pollak RM; Murphy MM; Epstein MP; Zwick ME; Klaiman C; Saulnier CA; ; Mulle JG
    Mol Autism; 2019; 10():30. PubMed ID: 31346402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients.
    Città S; Buono S; Greco D; Barone C; Alfei E; Bulgheroni S; Usilla A; Pantaleoni C; Romano C
    Am J Med Genet A; 2013 Dec; 161A(12):3018-22. PubMed ID: 24214349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
    Rutkowski TP; Purcell RH; Pollak RM; Grewenow SM; Gafford GM; Malone T; Khan UA; Schroeder JP; Epstein MP; Bassell GJ; Warren ST; Weinshenker D; Caspary T; Mulle JG
    Mol Psychiatry; 2021 Mar; 26(3):772-783. PubMed ID: 30976085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.
    Murphy MM; Lindsey Burrell T; Cubells JF; España RA; Gambello MJ; Goines KCB; Klaiman C; Li L; Novacek DM; Papetti A; Sanchez Russo RL; Saulnier CA; Shultz S; Walker E; Mulle JG
    BMC Psychiatry; 2018 Jun; 18(1):183. PubMed ID: 29884173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New phenotypes associated with 3q29 duplication syndrome: Results from the 3q29 registry.
    Pollak RM; Zinsmeister MC; Murphy MM; Zwick ME; ; Mulle JG
    Am J Med Genet A; 2020 May; 182(5):1152-1166. PubMed ID: 32154651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report.
    Murphy MM; Burrell TL; Cubells JF; Epstein MT; Espana R; Gambello MJ; Goines K; Klaiman C; Koh S; Russo RS; Saulnier CA; Walker E; ; Mulle JG
    BMC Psychiatry; 2020 Apr; 20(1):184. PubMed ID: 32321479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal oculogyric dystonia associated with a de novo 3q29 microdeletion.
    Kaur H; Thom RP; Neumeyer AM; Bilancia CG; Wray SH; McDougle CJ
    Psychiatr Genet; 2020 Aug; 30(4):119-123. PubMed ID: 32459710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity.
    Biamino E; Di Gregorio E; Belligni EF; Keller R; Riberi E; Gandione M; Calcia A; Mancini C; Giorgio E; Cavalieri S; Pappi P; Talarico F; Fea AM; De Rubeis S; Cirillo Silengo M; Ferrero GB; Brusco A
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):290-9. PubMed ID: 26620927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes for general behavior, activity, and body temperature in 3q29 deletion model mice.
    Mori D; Ikeda R; Sawahata M; Yamaguchi S; Kodama A; Hirao T; Arioka Y; Okumura H; Inami C; Suzuki T; Hayashi Y; Kato H; Nawa Y; Miyata S; Kimura H; Kushima I; Aleksic B; Mizoguchi H; Nagai T; Nakazawa T; Hashimoto R; Kaibuchi K; Kume K; Yamada K; Ozaki N
    Transl Psychiatry; 2024 Mar; 14(1):138. PubMed ID: 38453903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.
    Singh MD; Jensen M; Lasser M; Huber E; Yusuff T; Pizzo L; Lifschutz B; Desai I; Kubina A; Yennawar S; Kim S; Iyer J; Rincon-Limas DE; Lowery LA; Girirajan S
    PLoS Genet; 2020 Feb; 16(2):e1008590. PubMed ID: 32053595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel features of 3q29 deletion syndrome: Results from the 3q29 registry.
    Glassford MR; Rosenfeld JA; Freedman AA; Zwick ME; Mulle JG;
    Am J Med Genet A; 2016 Apr; 170A(4):999-1006. PubMed ID: 26738761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of the schizophrenia-associated 3q29 deletion.
    Pollak RM; Purcell RH; Rutkowski TP; Malone T; Pachura KJ; Bassell GJ; Epstein MP; Dawson PA; Smith MR; Jones DP; Zwick ME; Warren ST; Caspary T; Weinshenker D; Mulle JG
    Transl Psychiatry; 2022 Feb; 12(1):66. PubMed ID: 35177588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
    Kogan JH; Gross AK; Featherstone RE; Shin R; Chen Q; Heusner CL; Adachi M; Lin A; Walton NM; Miyoshi S; Miyake S; Tajinda K; Ito H; Siegel SJ; Matsumoto M
    J Neurosci; 2015 Dec; 35(49):16282-94. PubMed ID: 26658876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical case report and literature review of the 3q29 microdeletion syndrome.
    Cox DM; Butler MG
    Clin Dysmorphol; 2015 Jul; 24(3):89-94. PubMed ID: 25714563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series.
    Malt EA; Juhasz K; Frengen A; Wangensteen T; Emilsen NM; Hansen B; Agafonov O; Nilsen HL
    Mol Genet Genomic Med; 2019 Sep; 7(9):e889. PubMed ID: 31347308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review.
    Quintero-Rivera F; Sharifi-Hannauer P; Martinez-Agosto JA
    Am J Med Genet A; 2010 Oct; 152A(10):2459-67. PubMed ID: 20830797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular characterisation and phenotypic description of two patients with reciprocal chromosomal aberrations in the region of the 3q29 microdeletion/microduplication syndromes].
    Quintela I; Barros-Angueira F; Perez-Gay L; Dacruz D; Castro-Gago M; Carracedo A; Eiris-Punal J
    Rev Neurol; 2015 Sep; 61(6):255-60. PubMed ID: 26350776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.